Cargando…
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Alzheimer’s disease (AD) is commonly an age-associated dementia with neurodegeneration. The pathogenesis of AD is complex and still remains unclear. The inflammation, amyloid β (Aβ), and neurofibrillary tangles as well misfolded tau protein in the brain may contribute to the occurrence and developme...
Autores principales: | Zhu, Feiqi, Li, Chunrong, Chu, Fengna, Tian, Xiaoping, Zhu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572848/ https://www.ncbi.nlm.nih.gov/pubmed/33132894 http://dx.doi.org/10.3389/fnagi.2020.544235 |
Ejemplares similares
-
Can Control Infections Slow Down the Progression of Alzheimer’s Disease? Talking About the Role of Infections in Alzheimer’s Disease
por: Shi, Mingchao, et al.
Publicado: (2021) -
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
por: Shi, Mingchao, et al.
Publicado: (2022) -
Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2021) -
Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012) -
The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer’s Disease
por: Narengaowa,, et al.
Publicado: (2021)